XML 49 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statement of Operations (Unaudited) (USD $)
In Millions, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Consolidated Statement of Operations [Abstract]        
Revenues $ 11,361.4 [1] $ 11,288.8 [1] $ 22,455.9 [1] $ 22,427.2 [1]
Cost of revenues 10,577.3 [1] 10,531.3 [1] 20,926.3 [1] 21,006.5 [1]
Gross profit 784.1 757.5 1,529.6 1,420.7
Selling, general and administrative 204.8 227.2 397.9 435.7
Operating income 579.3 530.3 1,131.7 985.0
Other (expense) income:        
Interest income 1.5 0.5 1.9 2.2
Interest expense (50.3) (42.0) (90.0) (84.8)
Total other (expense) income (48.8) (41.5) (88.1) (82.6)
Income before income taxes 530.5 488.8 1,043.6 902.4
Provision for income taxes 196.3 181.5 382.9 334.5
Net income from continuing operations 334.2 307.3 660.7 567.9
Net loss from discontinued operations, net of tax 0 (17.4) 0 (17.8)
Net income $ 334.2 $ 289.9 $ 660.7 $ 550.1
Weighted average number of common shares outstanding during the period:        
Basic 502.6 544.5 515.7 547.1
Diluted 507.0 550.1 520.3 552.9
Basic earnings (loss) per share:        
Continuing operations $ 0.66 $ 0.56 $ 1.28 $ 1.04
Discontinued operations   $ (0.03)   $ (0.03)
Net earnings $ 0.66 $ 0.53 $ 1.28 $ 1.01
Diluted earnings (loss) per share:        
Continuing operations $ 0.66 $ 0.56 $ 1.27 $ 1.03
Discontinued operations   $ (0.03)   $ (0.03)
Net earnings $ 0.66 $ 0.53 $ 1.27 $ 0.99
[1] Includes retail pharmacy co-payments of $1,457.1 million and $1,547.3 million for the three months ended June 30, 2011 and 2010, respectively and $2,983.6 million and $3,209.9 million for the six months ended June 30, 2011 and 2010, respectively.